Clinical Spanish

Spanish for pulmonary hypertension clinic nurses — the patient newly diagnosed with PAH who cannot understand how she can have high blood pressure in her lungs when her arm blood pressure has always been normal, the patient on inhaled iloprost who refuses to use her nebulizer at work because her coworkers ask questions she cannot answer, and the patient who wants to know why she absolutely cannot become pregnant when she feels completely stable on her medications

Three pulmonary hypertension clinic conversations in Spanish: explaining why pulmonary arterial hypertension is an entirely separate circulatory system from the systemic blood pressure measured at the arm; explaining why inhaled iloprost doses skipped at work are a cumulative insult to a right ventricle with no reserve; and explaining why pregnancy carries a 25–50% maternal mortality risk in PAH regardless of how well the patient feels on treatment.

Why these three conversations

Adriana Castellanos is thirty-four years old. She is a bilingual customer service representative from Phoenix, and three weeks ago she was told she has pulmonary arterial hypertension. The diagnosis came after eighteen months of gradually worsening shortness of breath on exertion that she had attributed to being out of shape after her second pregnancy. Her primary care physician ordered an echocardiogram when she mentioned the symptom at a routine visit. The echocardiogram estimated a pulmonary artery systolic pressure of 55 millimeters of mercury and showed a dilated right ventricle. She was referred to the pulmonary hypertension clinic. A right heart catheterization done three weeks ago measured a mean pulmonary artery pressure of 38 millimeters of mercury, a pulmonary capillary wedge pressure of 10 millimeters of mercury, and a pulmonary vascular resistance of 6 Wood units. The diagnosis of pulmonary arterial hypertension, Group 1, was confirmed. She has been started on ambrisentan and tadalafil. Today she is at her first post-catheterization clinic visit, and before PAH clinic nurse Esperanza Maldonado can finish explaining the medication schedule, Adriana stops her: “Espera. ¿Cómo es posible que tenga presión alta en los pulmones si mi presión del brazo siempre ha sido completamente normal? El doctor siempre me dijo que mi presión estaba bien.”

Gloria Vega is forty-seven years old. She has been a hotel housekeeper in San Diego for twenty-two years, pushing a cleaning cart through eleven-hour shifts on floors where the elevator is a block and a half from the farthest room. She was diagnosed with PAH fourteen months ago, after a syncopal episode during her shift led to an emergency department evaluation. She is on inhaled iloprost six times daily — the first dose before work, doses two through five spaced through the workday, and the last dose after dinner. Eight months ago she started the iloprost, and within six weeks her six-minute walk test distance improved from 280 meters to 371 meters. Her functional class improved from III to II. She has not had another syncopal episode. At today’s visit, Esperanza Maldonado notes that Gloria’s six-minute walk test distance at this visit is 334 meters — down 37 meters from the peak. The pill count from her last visit suggests she is taking approximately four doses per day rather than six. When Esperanza asks about it directly, Gloria explains: “En el trabajo no puedo. La máquina hace ruido y mis compañeras me preguntan qué tengo. Yo no les he dicho nada. No quiero que me traten diferente ni que piensen que no puedo hacer mi trabajo.”

Valentina Morales is twenty-eight years old. She is a medical billing specialist from Albuquerque who was diagnosed with PAH two years ago when she developed progressive dyspnea during her commute. She is on ambrisentan 10 mg and tadalafil 40 mg daily. She is on a copper IUD for contraception because her PAH clinic team counseled her about the teratogenicity of ambrisentan before starting treatment. She and her husband were married four months ago. At today’s visit, her most recent right heart catheterization — done six weeks ago — showed a mean pulmonary artery pressure of 28 millimeters of mercury, down from 42 at diagnosis, and a pulmonary vascular resistance of 3.2 Wood units, down from 7.1. Her six-minute walk distance is 428 meters. She is asymptomatic at rest and has mild dyspnea only at maximal exertion. She has read about PAH and pregnancy extensively. She knows that ambrisentan is teratogenic. She is not using ambrisentan — she is already on copper IUD, so she is already preventing the teratogenic exposure. She asks PAH clinic nurse Gabriela López: “Entiendo que la ambrisentan daña al bebé. Pero tengo el DIU y no me pasa nada con eso. Mis números han mejorado. Me siento bien. ¿Por qué sigue siendo absolutamente imposible el embarazo?”

Each of these three patients carries into the clinic a model of her condition that is internally coherent but will produce serious harm if left intact. Adriana’s model is that blood pressure is one system monitored by the arm cuff, and that normal arm readings indicate cardiovascular health; she cannot see how a diagnosis of high blood pressure coexists with a ten-year history of normal readings. Gloria’s model is that the iloprost treatment is modifiable around her work schedule in the same way that a once-daily oral medication might be, and that the discomfort of workplace visibility is a legitimate reason to reorganize the dosing. Valentina’s model is that the teratogenicity warning is the primary reason for the pregnancy prohibition, and that reliable contraception while on the medication handles the risk the doctor described. Each model explains the patient’s behavior. None of them is survivable at current trajectory — Adriana will not follow a disease she does not believe she has; Gloria’s right ventricle is already paying for the missed doses in measurable walk distance; Valentina is one IUD expiration or displacement away from a lethal pregnancy.

Scenario 1 — Adriana Castellanos, 34, newly diagnosed with pulmonary arterial hypertension, mean PAP 38 mmHg, PVR 6 Wood units, asking PAH clinic nurse Esperanza Maldonado how she can have high blood pressure in her lungs when her arm blood pressure has always been normal

Esperanza Maldonado has worked in the pulmonary hypertension clinic for seven years. She has sat across from dozens of newly diagnosed patients who have left the right heart catheterization suite with a diagnosis they do not yet understand in a body that still feels, to them, essentially normal. She knows that Adriana is not being difficult. She is being coherent. Her model of blood pressure — the arm cuff, the systolic and diastolic number, the guidance from her primary care doctor over ten years that her blood pressure is fine — is correct as far as it goes. It just does not go far enough.

Esperanza decides to start not with the disease but with the anatomy — because the confusion is anatomical. Adriana does not have a wrong number in a system she understands; she has a system she does not yet know exists.

The two circulatory systems and why the arm cuff measures only one of them

Esperanza begins with a simple drawing on the paper covering the exam table. Two loops, connected by the heart in the middle.

Esperanza: “El corazón tiene dos lados que trabajan al mismo tiempo pero en circuitos separados. El lado izquierdo — el lado grande, el que la mayoría de la gente conoce — recibe sangre que viene de los pulmones ya con oxígeno, y la bombea por la aorta a todo el cuerpo: al cerebro, a los riñones, a los músculos, a las piernas. Eso es el circuito que el manguito del brazo mide. Su presión en ese circuito siempre ha sido normal. Eso sigue siendo verdad hoy.”

(The heart has two sides that work at the same time but in separate circuits. The left side — the large side, the one most people know — receives blood coming from the lungs already with oxygen, and pumps it through the aorta to the entire body: to the brain, to the kidneys, to the muscles, to the legs. That is the circuit the arm cuff measures. Your pressure in that circuit has always been normal. That is still true today.)

Adriana: “¿Y el lado derecho?”

(And the right side?)

Esperanza: “El lado derecho recibe la sangre que vuelve del cuerpo sin oxígeno, y la bombea a los pulmones para que se oxigene. Ese es el segundo circuito, y tiene su propia presión. La presión normal en las arterias que van de ese lado derecho a los pulmones es mucho más baja que la presión del cuerpo — normalmente menos de 20. El manguito del brazo no puede medir esa presión porque está midiendo solo el circuito del cuerpo. Para medir la presión del circuito de los pulmones, se necesita un catéter que llegue hasta la arteria pulmonar. Por eso fue necesario el procedimiento que le hicieron hace tres semanas.”

(The right side receives blood returning from the body without oxygen, and pumps it to the lungs to be oxygenated. That is the second circuit, and it has its own pressure. The normal pressure in the arteries going from that right side to the lungs is much lower than the body pressure — normally less than 20. The arm cuff cannot measure that pressure because it is measuring only the body circuit. To measure the pressure in the lung circuit, a catheter is needed that reaches the pulmonary artery. That is why the procedure done three weeks ago was necessary.)

Adriana is quiet for a moment. “Entonces son dos sistemas que van en paralelo. Uno puede estar bien y el otro mal al mismo tiempo.”

(Then they are two systems running in parallel. One can be fine and the other not at the same time.)

Esperanza: “Exactamente. El doctor de cabecera que le revisa la presión cada año está midiendo el lado izquierdo, el lado del cuerpo. No tiene manera de saber lo que está pasando en las arterias de los pulmones con el manguito del brazo. No es que se equivocó — es que el manguito no mide ese sistema.”

(Exactly. The primary care doctor who checks your blood pressure every year is measuring the left side, the body side. There is no way to know what is happening in the lung arteries with the arm cuff. It is not that he made a mistake — it is that the cuff does not measure that system.)

What pulmonary arterial hypertension is doing to Adriana’s pulmonary arteries and her right ventricle

Esperanza moves from the anatomy to the pathology. In pulmonary arterial hypertension — the Group 1 disease, the disease of the pulmonary arteries themselves, which is what Adriana has — the small pulmonary arteries and arterioles undergo structural remodeling. Their walls thicken. Their smooth muscle layer hypertrophies. The inner lining of the arteries proliferates. The lumen — the inside channel through which blood flows — narrows. This is not atherosclerosis. It is a different type of vascular remodeling, involving endothelial dysfunction and abnormal proliferative signaling in the pulmonary vascular smooth muscle. The result is a fixed increase in pulmonary vascular resistance: the lung arteries cannot dilate normally to accommodate increased blood flow, and the pressure required to push blood through them rises.

Adriana’s pulmonary vascular resistance at catheterization was 6 Wood units. Normal is less than 3. Her mean pulmonary artery pressure was 38 millimeters of mercury. Normal is less than 20. The right ventricle — the chamber that pumps blood into these narrowed arteries — is designed for low-pressure work. Its wall is thinner than the left ventricle. Its shape is different — it is crescent-shaped, wrapped around the left ventricle, designed to push blood into the low-resistance pulmonary circuit with modest pressure. When the circuit is no longer low-resistance, the right ventricle compensates by thickening its wall and generating higher pressure. But the right ventricle has a lower ceiling of reserve than the left. It can compensate for months to years, but ultimately, sustained high pulmonary vascular resistance causes right ventricular dysfunction, progressive dilation, and failure.

Esperanza: “Las arterias pequeñas de los pulmones se han ido engrosando por dentro — no como colesterol en las arterias del corazón, sino un tipo diferente de engrosamiento donde la pared muscular crece y la abertura se estrecha. Eso hace que la resistencia suba. El corazón derecho tiene que generar más presión para empujar la sangre a través. Como el corazón derecho no está diseñado para trabajar con alta presión — ese es el trabajo del izquierdo — se adapta engrosándose, pero tiene un límite. La dilatación del ventrículo derecho que vio el ecocardiograma es la respuesta del corazón al trabajo extra que está haciendo.”

(The small arteries in the lungs have been thickening from the inside — not like cholesterol in the heart arteries, but a different type of thickening where the muscular wall grows and the opening narrows. That makes the resistance rise. The right heart has to generate more pressure to push blood through. Since the right heart is not designed to work with high pressure — that is the left heart’s job — it adapts by thickening, but it has a limit. The right ventricle dilation that the echocardiogram showed is the heart’s response to the extra work it is doing.)

Adriana: “¿Y los medicamentos? ¿Pueden revertir eso?”

(And the medications? Can they reverse that?)

What ambrisentan and tadalafil do and what the treatment goal is

Esperanza explains the mechanism of the two medications Adriana has been started on. Both work on the pulmonary vasculature through different pathways, and understanding them requires understanding that the remodeled pulmonary arteries are not only structurally narrowed — they are also abnormally regulated.

Normally, the pulmonary arteries are kept in a balance between signals that promote vasoconstriction and vascular proliferation and signals that promote vasodilation and vascular stabilization. In PAH, this balance is disrupted: endothelin-1, a potent vasoconstrictor and smooth muscle mitogen, is overproduced; prostacyclin, a vasodilator that inhibits smooth muscle proliferation, is underproduced; and the nitric oxide–cyclic GMP pathway, which normally promotes vasodilation, is impaired. PAH drugs target these three pathways. Ambrisentan is an endothelin receptor antagonist — it blocks the receptor through which endothelin-1 promotes vasoconstriction and vascular remodeling. Tadalafil is a phosphodiesterase-5 inhibitor that prevents the breakdown of cyclic GMP, prolonging the vasodilatory signal from the nitric oxide pathway in the pulmonary vasculature.

Esperanza: “Los medicamentos no curan la enfermedad en el sentido de devolver las arterias a lo que eran antes. Lo que hacen es estabilizar el proceso — reducir la señal que hace que las arterias se sigan estrechando, y abrir un poco las que quedan. El objetivo del tratamiento es mantener al ventrículo derecho funcionando bien el mayor tiempo posible: que pueda seguir haciendo sus actividades, que la distancia que puede caminar no disminuya, que no tenga episodios de falla. Muchos pacientes con este tratamiento viven años con buena calidad de vida. Pero requiere tomarse los medicamentos todos los días, sin saltarse dosis, y seguimiento frecuente para ver cómo va el corazón derecho.”

(The medications do not cure the disease in the sense of returning the arteries to what they were before. What they do is stabilize the process — reduce the signal that makes the arteries continue to narrow, and open the ones that remain a little. The goal of treatment is to keep the right ventricle functioning well for as long as possible: that you can continue doing your activities, that the distance you can walk does not decrease, that you do not have heart failure episodes. Many patients with this treatment live years with good quality of life. But it requires taking the medications every day, without skipping doses, and frequent follow-up to see how the right heart is doing.)

Adriana: “¿Y si lo tomo bien y hago todo lo que dicen, puede mejorar la presión?”

(And if I take it correctly and do everything you say, can the pressure improve?)

Esperanza: “Sí. Hay pacientes cuya presión pulmonar y resistencia mejoran significativamente con el tratamiento combinado — a veces a niveles casi normales. Los que mejor responden son los que empiezan el tratamiento antes de que el ventrículo derecho esté muy dañado, que es el caso suyo ahora mismo. El catéter cardiaco en uno o dos años va a medir si los números están mejorando. Eso nos dice si el plan está funcionando.”

(Yes. There are patients whose pulmonary pressure and resistance improve significantly with combined treatment — sometimes to nearly normal levels. Those who respond best are those who begin treatment before the right ventricle is very damaged, which is your situation right now. The cardiac catheterization in one or two years will measure whether the numbers are improving. That tells us whether the plan is working.)

Scenario 2 — Gloria Vega, 47, on inhaled iloprost six times daily, six-minute walk distance declining from 371 to 334 meters, missing midday and afternoon doses at work, telling PAH clinic nurse Esperanza Maldonado she cannot use the nebulizer because her coworkers ask questions

Esperanza Maldonado has the pill count in her hand and the walk test result on the screen and she knows exactly what has happened before Gloria says anything. She has seen this pattern before. Inhaled iloprost is one of the most effective treatments for PAH but it is also one of the most behaviorally demanding: six to nine doses per day, spaced every two to three waking hours, each dose taking approximately ten minutes with the handheld Aerodyne nebulizer. The device is not silent. It produces an audible sound during inhalation. For a patient who has not disclosed her diagnosis to her employer or coworkers, six doses per day means several doses per shift in a hotel where she works alongside coworkers she has known for years and who have no idea that anything is wrong.

Esperanza does not open with the number. She opens with the walk test result and asks Gloria how she has been feeling.

Gloria: “Bien, más o menos. En el trabajo me canso más que antes — pero es el mismo trabajo de siempre.”

(Fine, more or less. At work I get more tired than before — but it is the same work as always.)

Esperanza: “La prueba de caminata de hoy fue 334 metros. La última visita fue 371. ¿Ha pasado algo con los medicamentos?”

(Today’s walk test was 334 meters. Last visit was 371. Has something happened with the medications?)

Why the iloprost dosing schedule is not adjustable and what missed doses do to the right ventricle

When Gloria explains the workplace problem, Esperanza listens without interrupting. Then she explains the pharmacokinetics — not to make Gloria feel guilty, but because the decision to skip doses is based on a model of the medication that is incorrect, and the correct model changes the calculus.

Esperanza: “El iloprost es diferente de los otros medicamentos que toma. La ambrisentan y el tadalafil son pastillas que el cuerpo absorbe y mantiene a un nivel estable durante el día. El iloprost inhalado no funciona así. Entra por los pulmones, llega directamente a las arterias pulmonares, y las abre. Pero ese efecto dura solo una hora, a veces dos. Cuando se pasa el efecto y no ha hecho la siguiente dosis, las arterias vuelven a donde estaban. El corazón derecho empieza a trabajar de más otra vez.”

(Iloprost is different from the other medications you take. Ambrisentan and tadalafil are pills the body absorbs and maintains at a stable level throughout the day. Inhaled iloprost does not work that way. It enters through the lungs, reaches the pulmonary arteries directly, and opens them. But that effect lasts only one hour, sometimes two. When the effect wears off and you have not taken the next dose, the arteries return to where they were. The right heart starts overworking again.)

Gloria: “¿Una hora?”

(One hour?)

Esperanza: “Una a dos horas por dosis. Por eso la prescripción dice seis veces al día espaciadas cada dos o tres horas. No es por precaución — es porque si hay más de tres horas sin dosis, el efecto se acaba. Las dos o tres dosis que está saltando en el trabajo son cuatro a seis horas de cada día de trabajo donde las arterias pulmonares no tienen el apoyo del medicamento. El corazón derecho paga esa diferencia. Y lo que estamos viendo hoy — que su caminata bajó de 371 a 334 metros — es lo que le cuesta al corazón derecho las dosis que se están saltando.”

(One to two hours per dose. That is why the prescription says six times per day spaced every two to three hours. It is not a precaution — it is because if there are more than three hours without a dose, the effect is gone. The two or three doses being skipped at work are four to six hours of every workday where the pulmonary arteries do not have the medication’s support. The right heart pays that difference. And what we are seeing today — that your walk dropped from 371 to 334 meters — is what the skipped doses are costing the right heart.)

Gloria is quiet. “¿La caminata bajó por las dosis?”

(The walk dropped because of the doses?)

Esperanza: “La caminata es la medida más directa que tenemos de cómo está aguantando el corazón derecho el trabajo que le pedimos. Cuando baja, el corazón está pagando más de lo que debería. Lo que logramos juntas hace ocho meses — pasar de 280 a 371 metros — fue con seis dosis al día. El plan de cuatro dosis está produciendo un resultado diferente.”

(The walk test is the most direct measure we have of how the right heart is tolerating the work we ask of it. When it drops, the heart is paying more than it should. What we achieved together eight months ago — going from 280 to 371 meters — was with six doses per day. The four-dose plan is producing a different result.)

Why the stigma concern is real and what a practical workplace plan looks like

Esperanza does not dismiss the workplace concern. She has watched patients make exactly this calculation — the visible medical device feels more threatening in the moment than the invisible right ventricular damage accumulating over weeks and months — and she knows that telling a patient the medication is non-negotiable without addressing the practical barrier produces nothing except a patient who nods in the clinic and continues the same pattern at work.

Esperanza: “Lo que usted siente sobre no querer que sus compañeras sepan es completamente válido. Nadie tiene obligación de explicar su diagnóstico en el trabajo. Lo que necesitamos es encontrar una manera de hacer el tratamiento sin que requiera esa explicación. El tratamiento es no negociable — las circunstancias de cómo lo hace sí son negociables.”

(What you feel about not wanting your coworkers to know is completely valid. No one is obligated to explain their diagnosis at work. What we need is to find a way to do the treatment without requiring that explanation. The treatment is non-negotiable — the circumstances of how you do it are negotiable.)

Esperanza asks about the physical layout of Gloria’s workplace. They work through the logistics. Hotel housekeeping schedules have a morning break and a lunch break. Gloria has access to the employee break room on the same floor she cleans, and there is a women’s restroom near the break room with a private stall. The treatment takes approximately ten minutes — nine to ten minutes with the Aerodyne nebulizer for a full dose. Ten minutes in the break room or restroom during the scheduled break is not unusual behavior and does not require disclosure.

Esperanza: “Para el descanso de la mañana y el almuerzo, ¿puede ir al baño o al cuarto de descanso con el equipo?”

(For the morning break and lunch, can you go to the bathroom or break room with the equipment?)

Gloria: “El descanso de la mañana sí. El almuerzo también. El problema es la dosis del mediodía entre los dos descansos.”

(The morning break, yes. Lunch too. The problem is the midday dose between the two breaks.)

Esperanza: “Esa dosis entre descansos es la que necesitamos cubrir. ¿Hay una manera de tomar cinco minutos en ese intervalo? En muchos trabajos, ir al baño durante la jornada es aceptable y no requiere explicación. La otra opción es hablar con recursos humanos — no para contar el diagnóstico, sino para pedir una acomodación médica de quince minutos adicionales durante el turno por una condición que requiere tratamiento durante el día. El médico puede escribir la carta de que la condición existe y que el tratamiento requiere ese tiempo, sin mencionar cuál es la condición.”

(That dose between breaks is the one we need to cover. Is there a way to take five minutes in that interval? In many workplaces, going to the bathroom during the shift is acceptable and requires no explanation. The other option is to talk to human resources — not to disclose the diagnosis, but to request a medical accommodation of fifteen additional minutes during the shift for a condition that requires daytime treatment. The doctor can write the letter that the condition exists and that the treatment requires that time, without mentioning which condition it is.)

Gloria considers this. “¿La carta no dice que tengo hipertensión pulmonar?”

(The letter does not say I have pulmonary hypertension?)

Esperanza: “No si usted no quiere. La ley permite pedir acomodación médica sin revelar el diagnóstico específico al empleador. El médico escribe que usted tiene una condición médica que requiere tratamiento durante el día. Eso es suficiente para la acomodación. Si prefiere no usar ese camino, la opción del baño para esa dosis es completamente privada. Y si alguien le pregunta qué hace, usted puede decir que tiene una condición respiratoria y que necesita unos minutos para un tratamiento. No tiene que decir más.”

(Not if you do not want it to. The law allows requesting medical accommodation without disclosing the specific diagnosis to the employer. The doctor writes that you have a medical condition that requires daytime treatment. That is enough for the accommodation. If you prefer not to use that path, the bathroom option for that dose is completely private. And if someone asks what you are doing, you can say you have a respiratory condition and that you need a few minutes for a treatment. You do not have to say more.)

They leave the visit with a concrete plan: morning break dose in the break room, midday dose in the bathroom stall during a bathroom visit, lunch dose during the lunch break, afternoon dose at the start of the post-lunch bathroom visit. Gloria will try this schedule for four weeks. The walk test at the next visit will tell them whether the plan is working.

Esperanza: “Si en cuatro semanas la caminata vuelve a 371 o más, sabremos que el plan funciona. Si baja más, tenemos que buscar otra solución. El objetivo no cambia: seis dosis al día, todos los días. Cómo llegar ahí — eso lo trabajamos juntas.”

(If in four weeks the walk test returns to 371 or more, we will know the plan works. If it drops more, we need to find another solution. The objective does not change: six doses per day, every day. How to get there — that we work on together.)

Scenario 3 — Valentina Morales, 28, PAH on ambrisentan and tadalafil, mean PAP improved from 42 to 28 mmHg, on copper IUD, recently married, asking PAH clinic nurse Gabriela López why pregnancy remains absolutely contraindicated when she feels stable and her numbers have improved

Gabriela López has been the PAH clinic nurse coordinator for nine years and she has had this conversation before — the young woman who is well-controlled, who understands the medication risks, who is using reliable contraception, who has done her research and who arrives at the clinic with a carefully constructed argument for why the prohibition should no longer apply to her specifically. She knows that Valentina’s argument is not unreasonable. It is based on real information. The problem is that the real information does not lead to the conclusion Valentina has drawn from it.

Gabriela respects the preparation. She does not begin by simply restating the prohibition. She begins by establishing what Valentina already knows correctly, because the conversation has to build from there.

Gabriela: “Usted entiende que la ambrisentan causa malformaciones en el bebé si se queda embarazada. Por eso tiene el DIU — para asegurarse de que no haya un embarazo mientras toma ese medicamento. Eso es correcto. La contraindicación de ambrisentan en el embarazo existe por teratogenicidad. Usted está manejando ese riesgo correctamente con el DIU.”

(You understand that ambrisentan causes malformations in the baby if you become pregnant. That is why you have the IUD — to ensure there is no pregnancy while taking that medication. That is correct. The contraindication of ambrisentan in pregnancy exists due to teratogenicity. You are managing that risk correctly with the IUD.)

Valentina: “Entonces si el DIU funciona, el problema está resuelto.”

(Then if the IUD works, the problem is solved.)

Gabriela: “Ese es el punto que necesito explicarle hoy. La contraindicación del embarazo en la hipertensión pulmonar no es principalmente por la ambrisentan. Es por lo que el embarazo le hace al corazón derecho. El DIU resuelve el problema de la teratogenicidad del medicamento. No resuelve el problema del embarazo en la hipertensión pulmonar — porque ese problema es hemodinámico, no farmacológico.”

(That is the point I need to explain to you today. The pregnancy contraindication in pulmonary hypertension is not primarily because of ambrisentan. It is because of what pregnancy does to the right heart. The IUD solves the problem of the medication’s teratogenicity. It does not solve the problem of pregnancy in pulmonary hypertension — because that problem is hemodynamic, not pharmacological.)

What normal pregnancy does to circulatory physiology and why the PAH right ventricle cannot accommodate it

Gabriela explains what happens to circulatory physiology during a normal pregnancy. By the end of the first trimester, blood volume begins to expand. By the third trimester, blood volume is 40 to 50 percent higher than the pre-pregnancy baseline. The heart must pump significantly more blood to supply both the mother’s organs and the placenta. Cardiac output rises 30 to 50 percent. Heart rate increases. In normal physiology, the pulmonary vasculature — which is a high-compliance, low-resistance circuit at baseline — accommodates this dramatically increased cardiac output by dilating: blood flow through the lungs increases without a significant rise in pulmonary artery pressure, because the pulmonary arteries can expand to receive more volume. The right ventricle handles the increased flow without significant pressure increase.

In PAH, the pulmonary arteries have already remodeled to a fixed increased resistance. They cannot dilate normally to accommodate increased blood volume. When blood volume rises 40 percent and cardiac output rises 30 to 50 percent during pregnancy, the right ventricle is required to generate even higher pressure than usual to push that increased volume through a circuit that has not expanded. The right ventricle — which was already operating near the limits of its reserve capacity at Valentina’s current mean pulmonary artery pressure of 28 millimeters of mercury and pulmonary vascular resistance of 3.2 Wood units — faces a sustained hemodynamic load that increases for nine months and peaks at delivery and in the immediate postpartum period, when fluid shifts are most abrupt.

Gabriela: “En el embarazo normal, el cuerpo fabrica un 40 por ciento más de sangre para alimentar a la madre y a la placenta. El corazón derecho tiene que bombear ese extra a través de las arterias de los pulmones. En una persona sin hipertensión pulmonar, las arterias se abren para dejar pasar esa sangre extra sin que suba la presión. En usted, las arterias ya no pueden abrirse de esa manera — la resistencia está fija. El corazón derecho tiene que empujar ese 40 por ciento extra a través de la misma resistencia. Y tiene que hacerlo nueve meses seguidos, con el pico más alto en el parto y los días después, cuando los fluidos cambian más rápido.”

(In a normal pregnancy, the body produces 40 percent more blood to feed the mother and the placenta. The right heart has to pump that extra through the lung arteries. In a person without pulmonary hypertension, the arteries open to let that extra blood through without the pressure rising. In you, the arteries can no longer open that way — the resistance is fixed. The right heart has to push that extra 40 percent through the same resistance. And it has to do it for nine consecutive months, with the highest peak at delivery and the days after, when fluids shift fastest.)

Valentina: “Pero mis números han mejorado. La resistencia bajó de 7.1 a 3.2. ¿No significa eso que el corazón está mejor?”

(But my numbers have improved. The resistance dropped from 7.1 to 3.2. Does that not mean the heart is better?)

Why improvement in PAH does not eliminate the pregnancy mortality risk

Gabriela acknowledges the improvement directly, because it is real and significant. Then she explains what it does and does not mean for the pregnancy question.

Gabriela: “La mejora de 7.1 a 3.2 Wood units es real y es importante. Significa que los medicamentos están funcionando y que el ventrículo derecho tiene menos trabajo que cuando empezó. Eso es exactamente lo que queríamos ver. Pero 3.2 Wood units sigue siendo el doble de la resistencia normal, que es menos de 3. Y lo que el embarazo exige — 40 por ciento más de volumen de sangre durante nueve meses — es una carga que va más allá de lo que el ventrículo derecho puede aguantar con seguridad incluso con esa mejora.”

(The improvement from 7.1 to 3.2 Wood units is real and important. It means the medications are working and the right ventricle has less work than when you started. That is exactly what we wanted to see. But 3.2 Wood units is still double the normal resistance, which is less than 3. And what pregnancy demands — 40 percent more blood volume over nine months — is a load that goes beyond what the right ventricle can safely sustain even with that improvement.)

Valentina: “¿Cuánto riesgo estamos hablando?”

(How much risk are we talking?)

Gabriela does not soften the number. She has learned that delivering a vague answer to this question — “the risk is high,” “the risk is serious” — allows patients to fill in a number that feels manageable. The actual number is not manageable.

Gabriela: “Los estudios en pacientes con hipertensión pulmonar en tratamiento — pacientes como usted, en medicamentos, con números que mejoraron, bajo cuidado médico — muestran mortalidad materna del 25 al 50 por ciento durante el embarazo y el postparto. Uno de cada cuatro a uno de cada dos. Ese número incluye pacientes que empezaron el embarazo sintómicamente estables, como usted lo está ahora. La falla del corazón derecho durante el embarazo en la hipertensión pulmonar puede ocurrir aunque la paciente haya estado bien antes. Y ocurre más seguido en el parto y el postparto inmediato, cuando los cambios hemodinámicos son más abruptos.”

(Studies in patients with pulmonary hypertension on treatment — patients like you, on medications, with numbers that improved, under medical care — show maternal mortality of 25 to 50 percent during pregnancy and the postpartum period. One in four to one in two. That number includes patients who began pregnancy symptomatically stable, as you are now. Right heart failure during pregnancy in pulmonary hypertension can occur even if the patient was doing well before. And it occurs most frequently at delivery and in the immediate postpartum period, when hemodynamic changes are most abrupt.)

Valentina does not speak for a moment.

Gabriela: “Sé que eso no es lo que quería escuchar. Y entiendo que la pregunta era legítima — us usted ha hecho todo correctamente: los medicamentos, el DIU, el seguimiento. El diagnóstico es serio, y lo está manejando seriamente. Lo que el embarazo exige al corazón derecho en la hipertensión pulmonar es diferente de lo que cualquier medicamento puede compensar. Los medicamentos pueden cambiar con el tiempo. La resistencia pulmonar que usted tiene ahora no va a cambiar lo suficiente durante un embarazo para hacer ese embarazo seguro.”

(I know that is not what you wanted to hear. And I understand the question was legitimate — you have done everything correctly: the medications, the IUD, the follow-up. The diagnosis is serious, and you are managing it seriously. What pregnancy demands of the right heart in pulmonary hypertension is different from what any medication can compensate for. The medications can change over time. The pulmonary resistance you have now will not change enough during a pregnancy to make that pregnancy safe.)

What contraception options are safe in PAH and what the conversation with a partner looks like

Gabriela then addresses the contraception question directly, because Valentina is on a copper IUD and that is actually one of the preferred options — but a complete picture of what is and is not safe in PAH is important for a woman in her twenties who will be making contraception decisions for years.

The copper IUD is highly effective and does not involve hormones that affect the pulmonary vasculature — it is appropriate for PAH. The levonorgestrel-releasing IUD (Mirena) is also generally acceptable in PAH because the progestin is primarily local with minimal systemic absorption. What is contraindicated in PAH is estrogen-containing contraception: combined oral contraceptive pills, the estrogen-containing patch, and the vaginal ring. Estrogen increases the risk of venous thromboembolism — deep vein thrombosis and pulmonary embolism — which is already an elevated risk in PAH patients, and estrogen may also have direct adverse effects on the pulmonary vasculature. Progestin-only pills and the etonogestrel implant (Nexplanon) are generally considered acceptable in PAH, though the implant efficacy and local hormonal effect make it a reasonable option for patients who prefer not to have an IUD.

Gabriela: “El DIU de cobre que tiene es una de las mejores opciones para usted. Es el más efectivo y no tiene hormonas que afecten los vasos pulmonares. Lo que no puede usar en la hipertensión pulmonar son los anticonceptivos que contienen estrógenos — las pastillas combinadas, el parche, el anillo vaginal. El estrógeno aumenta el riesgo de coágulos en la sangre y puede empeorar la presión en los pulmones. Lo que sí es aceptable: el DIU de cobre, el DIU hormonal de solo progesterona, la pastilla de solo progesterona, el implante de progesterona. Si el DIU de cobre le da problemas — algunos pacientes tienen más sangrado — hay opciones. Pero algo de alta efectividad y sin estrógenos es lo que necesita para siempre que esté en tratamiento para la hipertensión pulmonar.”

(The copper IUD you have is one of the best options for you. It is the most effective and has no hormones that affect the pulmonary vessels. What you cannot use in pulmonary hypertension are contraceptives containing estrogens — combined pills, the patch, the vaginal ring. Estrogen increases the risk of blood clots and can worsen pressure in the lungs. What is acceptable: the copper IUD, the hormonal progestin-only IUD, the progestin-only pill, the progestin implant. If the copper IUD causes problems — some patients have more bleeding — there are options. But something highly effective and without estrogen is what you need for as long as you are in treatment for pulmonary hypertension.)

Before Valentina leaves, Gabriela asks about the husband. Has he been part of these conversations?

Valentina: “Sabe que tengo la enfermedad, pero no hemos hablado de esto en detalle.”

(He knows I have the disease, but we have not discussed this in detail.)

Gabriela: “Le recomiendo que tengan esa conversación. No solo sobre el embarazo — también sobre el seguimiento, sobre lo que significa vivir bien con este diagnóstico, sobre qué planes de vida son seguros y cuáles requieren pensar diferente. Hay pacientes con hipertensión pulmonar que se convierten en madres — a través de adopción, a través de subrogación, a través de roles que no requieren el embarazo. Esas conversaciones valen la pena tenerlas con el tiempo que hay para planearlas, no en medio de una crisis. Si quieren venir juntos a una visita para tener esa conversación con el equipo, eso es algo que podemos hacer.”

(I recommend you have that conversation. Not just about pregnancy — also about follow-up, about what it means to live well with this diagnosis, about which life plans are safe and which ones require thinking differently. There are patients with pulmonary hypertension who become mothers — through adoption, through surrogacy, through roles that do not require pregnancy. Those conversations are worth having with the time to plan them, not in the middle of a crisis. If you both want to come to a visit to have that conversation with the team, that is something we can do.)

Eight practical phrases for pulmonary hypertension clinic nurses

  1. The two-circuit frame: “Son dos sistemas en paralelo: el manguito del brazo mide el circuito del cuerpo, y el catéter mide el circuito de los pulmones. Uno puede estar normal y el otro elevado al mismo tiempo.” (They are two parallel systems: the arm cuff measures the body circuit, and the catheter measures the lung circuit. One can be normal and the other elevated at the same time.)
  2. Why the right heart catheterization is necessary: “Solo el catéter puede medir la resistencia dentro de las arterias pulmonares. La resistencia es la que determina qué tipo de hipertensión pulmonar tiene y cuál es el medicamento correcto. Sin ese número, no podemos saber cuál es el tratamiento.” (Only the catheter can measure the resistance inside the pulmonary arteries. The resistance is what determines which type of pulmonary hypertension you have and which medication is correct. Without that number, we cannot know which is the treatment.)
  3. Iloprost half-life: “El iloprost dura una a dos horas por dosis. Cada dosis que salta son dos horas donde las arterias de los pulmones no tienen apoyo y el corazón derecho trabaja de más. No es como saltarse una pastilla de presión.” (Iloprost lasts one to two hours per dose. Every dose skipped is two hours where the lung arteries have no support and the right heart overworks. It is not like skipping a blood pressure pill.)
  4. Connecting walk test decline to missed doses: “La prueba de caminata mide cómo aguanta el corazón derecho. Cuando baja, el corazón está pagando más de lo que debería. La mejora que logramos fue con seis dosis al día. El plan de cuatro dosis produce un resultado diferente.” (The walk test measures how the right heart is tolerating the load. When it drops, the heart is paying more than it should. The improvement we achieved was with six doses per day. The four-dose plan produces a different result.)
  5. Workplace medication plan: “El tratamiento es no negociable. Los diez minutos y el lugar sí son negociables. Buscamos juntos un momento y un lugar donde pueda hacerlo con privacidad — el baño, el cuarto de descanso, el carro. El diagnóstico no tiene que ser parte de la conversación con nadie.” (The treatment is non-negotiable. The ten minutes and the place are negotiable. We find together a moment and a place where you can do it with privacy — the bathroom, the break room, the car. The diagnosis does not have to be part of the conversation with anyone.)
  6. Pregnancy mortality rate, stated directly: “Los estudios en pacientes con hipertensión pulmonar en tratamiento muestran mortalidad materna de 25 a 50 por ciento. Uno de cada cuatro a uno de cada dos. Eso incluye pacientes que empezaron el embarazo estables, como usted.” (Studies in patients with pulmonary hypertension on treatment show maternal mortality of 25 to 50 percent. One in four to one in two. That includes patients who began pregnancy stable, like you.)
  7. Why improvement does not eliminate the pregnancy risk: “La mejora en la resistencia es real. Pero el embarazo exige un 40 por ciento más de volumen de sangre durante nueve meses. La resistencia pulmonar que tiene ahora no va a cambiar lo suficiente durante el embarazo para que el corazón derecho pueda aguantar ese trabajo.” (The improvement in resistance is real. But pregnancy demands 40 percent more blood volume over nine months. The pulmonary resistance you have now will not change enough during pregnancy for the right heart to sustain that work.)
  8. Safe contraception in PAH: “El DIU de cobre y los métodos de solo progesterona son las opciones más seguras. Los anticonceptivos con estrógenos — las pastillas combinadas, el parche, el anillo — aumentan el riesgo de coágulos y pueden empeorar la presión pulmonar. No son una opción.” (The copper IUD and progestin-only methods are the safest options. Estrogen-containing contraceptives — combined pills, the patch, the ring — increase clotting risk and can worsen pulmonary pressure. They are not an option.)

Why these conversations are different from what the pulmonology clinic post covers

Pulmonary hypertension is a subspecialty of pulmonology and cardiology with a disease-specific patient population, disease-specific medications, and communication challenges that do not appear in general pulmonology clinic nursing. The existing ClinicaLingo post on Spanish for pulmonology clinic nurses covers asthma, COPD, and chronic respiratory conditions where the mechanism, the medication approach, and the patient education framework are entirely different. PAH involves three unique clinical communication challenges not found elsewhere in the blog library:

The systemic-versus-pulmonary hypertension confusion is specific to PAH and does not arise in any other nursing setting. No other condition produces a patient who has been told for ten years that her blood pressure is normal and who is now being asked to understand that she has hypertension in a circuit that the arm cuff does not measure. The explanation requires building an anatomical framework — two parallel circulatory systems, one measured by the cuff and one requiring a catheter — that is not required in any other disease-education context.

The inhaled prostacyclin adherence challenge is specific to PAH because no other class of medication has the short half-life and frequent dosing requirement of inhaled iloprost. The behavioral demand of six to nine inhalations per day in the workplace, with a visible and audible device, in patients who frequently have not disclosed their diagnosis to their employer, creates a socially complex adherence problem that has no analog in any other medication category covered in the blog library.

The absolute pregnancy contraindication based on hemodynamics rather than teratogenicity is specific to PAH and is one of the most ethically and emotionally complex conversations in all of pulmonary medicine. The maternal mortality rate of 25–50% in treated patients makes this contraindication more restrictive than virtually any other medical prohibition a young woman will encounter in primary care or specialist medicine. The communication challenge — explaining why improvement in measurable numbers does not make the prohibition revisable — requires a hemodynamic explanation that belongs only to this disease.

Practice the phrases and the explanations at the ClinicaLingo practice module and download the 50 ED phrases PDF as a reference for the shift. Browse the full library of 175 clinical specialty posts for pulmonology clinic, cardiology clinic, infectious disease clinic, and more.

Internal links for further reading